Genetic variation of Neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes

被引:8
作者
Li, J. [1 ]
Bergmann, A.
Reimann, M. [1 ]
Schulze, J. [1 ]
Bornstein, S. R. [1 ]
Schwarz, P. E. H. [1 ]
机构
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Clin 3, Dept Endocrinopathies & Metab Dis, D-01309 Dresden, Germany
关键词
Neurogenin; 3; proinsulin; progression of type 2; diabetes;
D O I
10.1055/s-2007-992156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Transcription factor Neurogenin 3 (NGN3) is considered as a candidate gene for the development of type 2 diabetes. The aim of the current study was to investigate the relevance of NGN3 variants for the clinical spectrum of diabetes development and disease progressions. Research Design and Methods: A total of 552 subjects with increased risk of type 2 diabetes were investigated. They underwent a 75g OGTT with measurements of plasma glucose, insulin and proinsulin at fasting and at 30, 60,90 and 120 minutes after the glucose challenge, repeated after 3 years. The NGN3 SNPs, Gly167Arg and Ser199Phe were genotyped. Result: Patients with type 2 diabetes carrying the variant genotype at SNP199 presented with significantly higher proinsulin levels. Proinsulin level was also associated with progression of diabetes mellitus. There was a discrete association of the Ser199Phe variant with evolution of the disease status. Conclusion: A genetic variation in NGN3 gene may be among the genetic determinants involved in the pathogenesis of diabetes.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 42 条
[21]   A novel mutation (E333D) in the thyroid hormone β receptor causing resistance to thyroid hormone syndrome [J].
Maraninchi, M. ;
Bourcigaux, N. ;
Dace, A. ;
El-Yazidi, C. ;
Malezet-Desmoulins, C. ;
Krempf, M. ;
Torresani, J. ;
Margotat, A. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (10) :569-576
[22]   Variants of neurogenin 3 gene are not associated with Type II diabetes in Japanese subjects [J].
Okada, T ;
Tobe, K ;
Hara, K ;
Yasuda, K ;
Kawaguchi, Y ;
Ikegami, H ;
Ito, C ;
Kadowaki, T .
DIABETOLOGIA, 2001, 44 (02) :241-244
[23]   Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort [J].
Olckers, Antonel ;
Towers, G. Wayne ;
van der Merwe, Annelize ;
Schwarz, Peter E. H. ;
Rheeder, Paul ;
Schutte, Aletta E. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (05) :587-592
[24]   Depression and anxiety symptoms in diabetic patients on continuous subcutaneous insulin infusion (CSII) [J].
Reichel, A ;
Schwarz, J ;
Schulze, J ;
Licinio, J ;
Wong, ML ;
Bornstein, SR .
MOLECULAR PSYCHIATRY, 2005, 10 (11) :975-976
[25]   An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes [J].
Schulze, Matthias B. ;
Hoffmann, Kurt ;
Boeing, Heiner ;
Linseisen, Jakob ;
Rohrmann, Sabine ;
Moehlig, Matthias ;
Pfeiffer, Andreas F. H. ;
Spranger, Joachim ;
Thamer, Claus ;
Haering, Hans-Ulrich ;
Fritsche, Andreas ;
Joost, Hans-Georg .
DIABETES CARE, 2007, 30 (03) :510-515
[26]   High risk strategy in diabetes prevention - pro [J].
Schwarz, P .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (17) :1103-1103
[27]  
Schwarz P E H, 2005, Exp Clin Endocrinol Diabetes, V113, P475, DOI 10.1055/s-2005-865942
[28]   Congress report from the American Diabetes Association - 66th Annual Scientific Sessions in Washington, USA [J].
Schwarz, P. E. H. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (10) :605-610
[29]   Diabetes prevention - From physiology to implementation [J].
Schwarz, P. E. H. ;
Schwarz, J. ;
Bornstein, S. R. ;
Schulze, J. .
HORMONE AND METABOLIC RESEARCH, 2006, 38 (07) :460-464
[30]   Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population [J].
Schwarz, P. E. H. ;
Govindarajalu, S. ;
Towers, W. ;
Schwanebeck, U. ;
Fischer, S. ;
Vasseur, F. ;
Bornstein, S. R. ;
Schulze, J. .
HORMONE AND METABOLIC RESEARCH, 2006, 38 (07) :447-451